Adagene (Suzhou) Limited
2 clinical trials · Sponsor
◉ Watch Adagene (Suzhou) Limited
| Record | Firm | Date |
|---|---|---|
| Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma (NCT04775680) | Adagene (Suzhou) Limited | 2021-03-11 |
| Study of ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma (NCT03802955) | Adagene (Suzhou) Limited | 2018-12-20 |
Track Adagene (Suzhou) Limited automatically
Every clearance here is in the API, with alerts when new ones post.